Shenzhen Neptunus Interlong Bio-technique Company Limited reported earnings results for the full year ended December 31, 2023. For the full year, the company reported sales was CNY 1,064.86 million compared to CNY 986.69 million a year ago. Net income was CNY 24.13 million compared to CNY 54.35 million a year ago.

Basic earnings per share from continuing operations was CNY 0.0144 compared to CNY 0.0324 a year ago.